Literature DB >> 24764672

Hepcidin expression in colon during trinitrobenzene sulfonic acid-induced colitis in rats.

Érica Martins Ferreira Gotardo1, Gilberto de Almeida Ribeiro1, Thayane Rodrigues Leite Clemente1, Camila Henrique Moscato1, Renata Bortolin Guerra Tomé1, Thalita Rocha1, José Pedrazzoli1, Marcelo Lima Ribeiro1, Alessandra Gambero1.   

Abstract

AIM: To investigate hepcidin expression, interleukin-6 (IL-6) production and iron levels in the rat colon in the presence of trinitrobenzene sulfonic acid (TNBS)-induced colitis.
METHODS: In rats, we evaluated the severity of colitis induced by repeated TNBS administration using macroscopic and microscopic scoring systems and myeloperoxidase activity measurements. The colonic levels of hepcidin, tumor necrosis factor alpha (TNF-α), IL-10 and IL-6 were measured by Enzyme-Linked Immunosorbent Assay, and hepcidin-25 expression and iron deposition were analyzed by immunohistochemistry and the Prussian blue reaction, respectively. Stat-3 phosphorylation was assessed by Western blot analysis. Hematological parameters, iron and transferrin levels, and transferrin saturation were also measured. Additionally, the ability of iron, pathogen-derived molecules and IL-6 to induce hepcidin expression in HT-29 cells was evaluated.
RESULTS: Repeated TNBS administration to rats resulted in macroscopically and microscopically detectable colon lesions and elevated colonic myeloperoxidase activity. Hepcidin-25 protein levels were increased in colonic surface epithelia in colitic rats (10.2 ± 4.0 pg/mg protein vs 71.0 ± 8.4 pg/mg protein, P < 0.01). Elevated IL-6 levels (8.2 ± 1.7 pg/mg protein vs 14.7 ± 0.7 pg/mg protein, P < 0.05), TNF-α levels (1.8 ± 1.2 pg/mg protein vs 7.4 ± 2.1 pg/mg protein, P < 0.05) and Stat-3 phosphorylation were also observed. Systemic alterations in iron homeostasis, hepcidin levels and anemia were not detected in colitic rats. Iron deposition in the colon was only observed during colitis. Hepcidin gene expression was increased in HT-29 cells after IL-6 and lipopolysaccharide [a toll-like receptor 4 (TLR-4) ligand] treatment. Deferoxamine, ferric citrate and peptidoglycan (a TLR-2 ligand) were unable to alter the in vitro expression of hepcidin in HT-29 cells.
CONCLUSION: Colitis increased local hepcidin-25 expression, which was associated with the IL-6/Stat-3 signaling pathway. An increase in local iron sequestration was also observed, but additional studies are needed to determine whether this sequestration is a defensive or pathological response to intestinal inflammation.

Entities:  

Keywords:  Anemia; Hepcidin-25; Interleukin-6; Iron; Stat-3; Toll-like receptor 4

Mesh:

Substances:

Year:  2014        PMID: 24764672      PMCID: PMC3989970          DOI: 10.3748/wjg.v20.i15.4345

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Micronutrients and inflammatory bowel disease.

Authors:  Gerard E Mullin
Journal:  Nutr Clin Pract       Date:  2012-01-05       Impact factor: 3.080

Review 2.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

3.  Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.

Authors:  Maria Elena Rodríguez-Cabezas; Julio Gálvez; Maria Dolores Lorente; Angel Concha; Desirée Camuesco; Shamira Azzouz; Antonio Osuna; Luis Redondo; Antonio Zarzuelo
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

Review 4.  Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin.

Authors:  Lisa Tussing-Humphreys; Cenk Pusatcioglu; Cenk Pustacioglu; Elizabeta Nemeth; Carol Braunschweig
Journal:  J Acad Nutr Diet       Date:  2012-03-01       Impact factor: 4.910

5.  Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.

Authors:  Thayane Rodrigues Leite Clemente; Aline Noronha Dos Santos; José Narciso Sturaro; Erica Martins Ferreira Gotardo; Caroline Candida de Oliveira; Simone Coghetto Acedo; Cintia Rabelo E Paiva Caria; José Pedrazzoli; Marcelo Lima Ribeiro; Alessandra Gambero
Journal:  Scand J Gastroenterol       Date:  2012-05-28       Impact factor: 2.423

6.  A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.

Authors:  Tohru Funakoshi; Kenichiro Yamashita; Nobuki Ichikawa; Moto Fukai; Tomomi Suzuki; Ryoichi Goto; Tetsu Oura; Nozomi Kobayashi; Takehiko Katsurada; Shin Ichihara; Michitaka Ozaki; Kazuo Umezawa; Satoru Todo
Journal:  J Crohns Colitis       Date:  2011-09-21       Impact factor: 9.071

Review 7.  Iron sequestration and anemia of inflammation.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

8.  Autocrine formation of hepcidin induces iron retention in human monocytes.

Authors:  Igor Theurl; Milan Theurl; Markus Seifert; Sabine Mair; Manfred Nairz; Holger Rumpold; Heinz Zoller; Rosa Bellmann-Weiler; Harald Niederegger; Heribert Talasz; Günter Weiss
Journal:  Blood       Date:  2007-12-11       Impact factor: 22.113

9.  Mesenteric adipose tissue alterations resulting from experimental reactivated colitis.

Authors:  Alessandra Gambero; Marta Maróstica; Mario José Abdalla Saad; José Pedrazzoli
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

10.  Increased hepcidin expression in colorectal carcinogenesis.

Authors:  Douglas G Ward; Keith Roberts; Matthew J Brookes; Howard Joy; Ashley Martin; Tariq Ismail; Robert Spychal; Tariq Iqbal; Chris Tselepis
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

View more
  1 in total

1.  Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.

Authors:  Jorge E Toblli; Gabriel Cao; Margarita Angerosa
Journal:  Drug Des Devel Ther       Date:  2015-05-07       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.